Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | AGER | Q15109 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | MYC | P01106 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | NAPRT | Q6XQN6 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.39 |
| ▸ | ASPH | Q12797 | 1/20 | 0.39 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL16239168 | 0.98 | KDM4E (0.53) | KDM4EALDH1A1MAPTL3MBTL1CYP3A4 | |
| SCHEMBL16239166 | 0.83 | KDM4E (0.40) | KDM4EALDH1A1MAPTL3MBTL1CYP3A4 | |
| SCHEMBL2840909 | 0.83 | KDM4E (0.40) | KDM4EALDH1A1MAPTL3MBTL1CYP3A4 | |
| SCHEMBL31628026 | 0.83 | ALDH1A1 (0.41) | KDM4EALDH1A1MAPTL3MBTL1CYP3A4 | |
| SCHEMBL547926 | 0.82 | KDM4E (0.57) | KDM4EALDH1A1MAPTL3MBTL1CYP3A4 | |
| SCHEMBL14567324 | 0.79 | KDM4E (0.36) | KDM4EALDH1A1MAPTL3MBTL1CYP3A4 | |
| SCHEMBL13388358 | 0.79 | MAPT (0.37) | KDM4EALDH1A1MAPTL3MBTL1CYP3A4 | |
| SCHEMBL535731 | 0.79 | L3MBTL1 (0.55) | KDM4EALDH1A1MAPTL3MBTL1CYP3A4 | |
| SCHEMBL16239167 | 0.79 | L3MBTL1 (0.37) | KDM4EALDH1A1MAPTL3MBTL1CYP3A4 | |
| SCHEMBL13379447 | 0.79 | MAPK1 (0.39) | KDM4EALDH1A1MAPTL3MBTL1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6271386-B1 | COMPLEXABLE WITH ACTIVE AGROCHEMICAL, PHARMACEUTICAL OR COSMETIC AGENTS FOR CONTROLLED RELEASE THEREOF; LAUNDRY DETERGENT OR RINSING COMPOSITION. | ISP INVESTMENTS INC. | 2001-08-07 | — | — | US | claimed |
| US-6156829-A | Product and process for making quaternized, water soluble vinylpyridine carboxylate polymers | ISP INVESTMENTS INC. (US) | 2000-12-05 | — | — | US | claimed |
| WO-2000035880-A1 | QUATERNIZED WATER SOLUBLE VINYLPYRIDINE CARBOXYLATE POLYMERS | ISP INVESTMENTS INC. (US) | 2000-06-22 | — | — | WO | claimed |
| WO-2000035881-A1 | QUATERNIZED WATER SOLUBLE VINYLPYRIDINE CARBOXYLATE POLYMERS | ISP INVESTMENTS, INC. (US) | 2000-06-22 | — | — | WO | claimed |
| JP-6202178-A | — | — | None | — | — | JP | disclosed |
| CN-115551862-B | Macrocyclic inhibitors of peptidyl arginine deiminase | 吉利德科学公司 | 2024-04-12 | — | — | CN | disclosed |
| CN-108950645-B | Aluminum and aluminum alloy anodic oxidation nickel-free sealing agent | 上海铝通化学科技有限公司 | 2020-10-23 | — | — | CN | disclosed |
| CN-108950645-A | A kind of aluminium and aluminium alloy anode oxide are without nickel sealer | 上海铝通化学科技有限公司 | 2018-12-07 | — | — | CN | disclosed |
| US-20170355689-A1 | HEPATITIS C VIRUS INHIBITOR | BRISTOL MYERS SQUIBB CO (US) | 2017-12-14 | — | — | US | disclosed |
| US-20170355689-A1 | HEPATITIS C VIRUS INHIBITOR | BRISTOL MYERS SQUIBB CO (US) | 2017-12-14 | — | — | US | disclosed |
| EP-2601188-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2017-10-18 | — | — | EP | disclosed |
| US-9776981-B2 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-10-03 | — | — | US | disclosed |
| US-6156829-A | Product and process for making quaternized, water soluble vinylpyridine carboxylate polymers | ISP INVESTMENTS INC. (US) | 2000-12-05 | — | — | US | disclosed |
| US-6156829-A | Product and process for making quaternized, water soluble vinylpyridine carboxylate polymers | ISP INVESTMENTS INC. (US) | 2000-12-05 | — | — | US | disclosed |
| US-6156829-A | Product and process for making quaternized, water soluble vinylpyridine carboxylate polymers | ISP INVESTMENTS INC. (US) | 2000-12-05 | — | — | US | disclosed |
| WO-2000035880-A1 | QUATERNIZED WATER SOLUBLE VINYLPYRIDINE CARBOXYLATE POLYMERS | ISP INVESTMENTS INC. (US) | 2000-06-22 | — | — | WO | disclosed |
| WO-2000035880-A1 | QUATERNIZED WATER SOLUBLE VINYLPYRIDINE CARBOXYLATE POLYMERS | ISP INVESTMENTS INC. (US) | 2000-06-22 | — | — | WO | disclosed |
| WO-2000035881-A1 | QUATERNIZED WATER SOLUBLE VINYLPYRIDINE CARBOXYLATE POLYMERS | ISP INVESTMENTS, INC. (US) | 2000-06-22 | — | — | WO | disclosed |
| WO-2000035881-A1 | QUATERNIZED WATER SOLUBLE VINYLPYRIDINE CARBOXYLATE POLYMERS | ISP INVESTMENTS, INC. (US) | 2000-06-22 | — | — | WO | disclosed |
| JP-H06202178-A | ORGANIC NONLINEAR OPTICAL MATERIAL | SEKISUI CHEM CO LTD | 1994-07-22 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170355689-A1 | HEPATITIS C VIRUS INHIBITOR | HAVCR2, LIPC, PYGL | KDM4E 3740/4885ALDH1A1 1107/4885MAPT 3923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.